This year's theme, "The evidence is clear: Invest in prevention," emphasizes the need for drug policies rooted in science, respect for human rights. The World Drug Report also released today, emphasizing continued international collaboration to prevent drug abuse.
The Substance Abuse and Mental Health Services Administration (SAMHSA) released the 2022 Drug Abuse Warning Network (DAWN) report on drug-related emergency department (ED) visits.
Analyzing data from 1999 to 2019, researchers found that marijuana legalization is associated with higher opioid death rates, contradicting the marijuana protection hypothesis which proposes that the availability of marijuana reduces deaths from opioids.
In a study of 211 patients from the greater New York area, subjects using marijuana were 86% more likely to engage in non-medical opioid use (ie took more than prescribed or used illicit opioids).
Will buprenorphine become the next oxycontin? Due to a major shift in addiction medicine policy, it just might. Last Thursday the Trump administration relaxed prescribing rules for the powerful synthetic opioid prescribed for both moderate to severe pain and opioid replacement therapy.
According to a newly published study in JAMA, neonatal abstinence [...]
According to a newly published study in JAMA, neonatal abstinence [...]
Check out and share the following three new resources: The Impacts of COVID-19 on Substance Use, Opioid Overdose, and Treatment; Substance Use and Mental Health Implications for the Workplace; and Kratom.
The COVID-19 pandemic has exacerbated challenges for millions of adults with substance use disorders. New obstacles for obtaining treatment exist as do increasing stressors, including isolation, unemployment, and illness.
We're excited to announce the development of four new prevention [...]
